Drugs & Targets Approvals Granted to Darzalex and Ninlaro in Multiple Myeloma November 20, 2015Vol.41 No.43
Capitol Hill FDA Lists Potentially Avoidable Harms in 20 LDT Case Studies, Including Tests from Duke, Caris and Genomic Health November 20, 2015Vol.41 No.43By Conor Hale
CBER’s All-Day Voyage into Slippery Science Ends in 18-6 Vote against Bladder Drug November 20, 2015Vol.41 No.43By Paul Goldberg
Drugs & Targets Tagrisso Granted Accelerated Approval in Non-Small Cell Lung Cancer November 13, 2015Vol.41 No.42
